SEROUS OVARIAN TUMOR
Clinical trials for SEROUS OVARIAN TUMOR explained in plain language.
Never miss a new study
Get alerted when new SEROUS OVARIAN TUMOR trials appear
Sign up with your email to follow new studies for SEROUS OVARIAN TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a plant compound protect cancer patients from dangerous blood clots?
Disease control Recruiting nowThis study is testing whether a plant-based supplement called isoquercetin can reduce markers in the blood that indicate risk of blood clots in people with ovarian cancer. Researchers will compare the effects of isoquercetin against a placebo in 90 participants who are receiving …
Matched conditions: SEROUS OVARIAN TUMOR
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Second chance: testing drug again after surgery to control ovarian cancer spread
Disease control Recruiting nowThis study is testing whether giving the drug niraparib again after surgery can help control ovarian cancer that has returned in a limited way. It will include 30 women whose cancer spread to 1-5 spots after previous treatment with similar drugs. The main goal is to see how long …
Matched conditions: SEROUS OVARIAN TUMOR
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Feb 24, 2026 14:07 UTC